| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 08/19/1997 | US5658767 Plant extract; vegetable oil; infant's formula |
| 08/19/1997 | US5658576 Method for combatting cellulitis or reducing localized fatty excesses |
| 08/19/1997 | CA2126208C Anti-obesity agent |
| 08/14/1997 | WO1997029180A1 Diabetes therapy |
| 08/14/1997 | WO1997029131A1 HUMAN ANTIBODIES THAT BIND HUMAN TNF$g(a) |
| 08/14/1997 | WO1997029109A1 Pyrazolopyrimidines as crf receptor antagonists |
| 08/14/1997 | WO1997028824A1 Obesity protein compounds and formulations thereof |
| 08/14/1997 | WO1997028813A1 Mixtures derived from grains of eugenia jambolana lamarck, preparation and use of said mixtures and some of their constituents as medicaments |
| 08/14/1997 | WO1997028808A1 Methods of inhibiting leaderless protein export using cardiac glycosides or aglycones therefrom and derivatives |
| 08/14/1997 | WO1997028806A1 Treatment for hypercholesterolemia |
| 08/14/1997 | CA2243718A1 Diabetes therapy |
| 08/14/1997 | CA2242245A1 Methods of inhibiting leaderless protein export using cardiac glycosides or aglycones therefrom and derivatives |
| 08/13/1997 | EP0788514A1 Binding agents for treatment of inflammatory, autoimmune or allergic diseases |
| 08/13/1997 | EP0788513A1 Binding agents to cd23 |
| 08/13/1997 | EP0788512A1 Proinsulin peptide compounds for detecting and treating type i diabetes |
| 08/13/1997 | EP0788509A1 Therapeutic peptide derivatives |
| 08/13/1997 | EP0788496A1 Apolipoprotein-b synthesis inhibitors |
| 08/13/1997 | EP0788478A1 Azetidinone derivatives for the treatment of atherosclerosis |
| 08/13/1997 | EP0788362A1 Phosponocarboxylate compounds for treating abnormal calcium and phosphate metabolism |
| 08/13/1997 | EP0788361A1 Novel compositions based on a synergistic combination of one or more vrd ligands and retinoids |
| 08/13/1997 | EP0788352A1 Treatment of animals |
| 08/13/1997 | EP0567490B1 Non-depleting cd4-specific monoclonal antibodies for the treatment of insulin-dependent diabetes mellitus (iddm) |
| 08/13/1997 | CN1156965A Cytokine regulatory agents and method of use in pathologies and conditions associated with altered cytokine levels |
| 08/13/1997 | CN1156955A Application of phospholipases in animal feed |
| 08/13/1997 | CN1156607A Shuangwujiangtang capsule for reducing blood sugar |
| 08/13/1997 | CN1156601A Blood-fat reducing medicine and preparing process thereof |
| 08/12/1997 | US5656726 Antiinflammatory agents, antiarthritic agents |
| 08/12/1997 | US5656722 A21 -, B30 - modified insulin derivatives having an altered action profile |
| 08/12/1997 | US5656721 Having sugar moiety; prolonged duration of action |
| 08/12/1997 | US5656667 Fatty acid composition |
| 08/12/1997 | US5656656 Drug for treating osteoporosis bone disorder |
| 08/12/1997 | US5656648 Treatment of pathologies necessitating stimulation of cholecystokinin-a receptors by total or partial agonist effect |
| 08/12/1997 | US5656624 4-[(heterocycloalkyl or heteroaromatic)-substituted phenyl]-2-azetidinones useful as hypolipidemic agents |
| 08/12/1997 | US5656598 Use of fibroblast growth factors to stimulate bone growth |
| 08/12/1997 | US5656590 Administering amylin or derivatives to increase the amylin level of plasma of the patient |
| 08/12/1997 | US5656481 Compositions and methods for the delivery of biologically active molecules using cells contained in biocompatible capsules |
| 08/12/1997 | US5656455 Adenylate cyclase stimulating factor |
| 08/12/1997 | US5656308 Non-reducing oligosaccharide with neotrehalose structure, and its production and uses |
| 08/12/1997 | US5656255 Composition to help stop smoking |
| 08/07/1997 | WO1997028191A1 Mhc complexes and uses thereof |
| 08/07/1997 | WO1997028189A1 Methods for increasing endogenous levels of corticotropin-releasing factor |
| 08/07/1997 | WO1997028153A1 Chinoline and benzimidazole derivatives as bradykinin agonists |
| 08/07/1997 | WO1997028137A1 Heterocyclic derivatives as antidiabetic and antiobesity agents |
| 08/07/1997 | WO1997028128A1 Heterocyclic compounds useful as pharmaceutical agents |
| 08/07/1997 | WO1997028115A1 Antidiabetic agents |
| 08/07/1997 | WO1997027857A1 Antidiabetic agents |
| 08/07/1997 | WO1997027847A1 Method of treating diabetes and related disease states |
| 08/07/1997 | WO1997027764A1 Food and vitamin preparations containing the natural isomer of reduced folates |
| 08/07/1997 | CA2245529A1 Antidiabetic agents |
| 08/07/1997 | CA2245524A1 Antidiabetic agents |
| 08/07/1997 | CA2244831A1 Method of treating diabetes and related disease states |
| 08/07/1997 | CA2244755A1 Mhc complexes and uses thereof |
| 08/06/1997 | EP0787741A1 Amylin isolated from pancreatic islet amyloid and pharmaceutical compositions comprising it |
| 08/06/1997 | EP0787739A1 Anti-adhesive piperidine and pyrollidine -carboxylic acids |
| 08/06/1997 | EP0787725A1 Quinoline derivative |
| 08/06/1997 | EP0787499A1 Kininogen for promoting bone formation and inhibiting bone resorption |
| 08/06/1997 | EP0787492A1 Use of nitroxides and oxazolidines for protection against ionising radiation and oxidative stress |
| 08/06/1997 | EP0787489A2 Composition containing L-carnitine or alkanoyl-L-carnitine and hydroxycitric acid or pantothenic acid |
| 08/06/1997 | EP0786987A1 Enterogenin pharmaceutical form |
| 08/06/1997 | EP0594612B1 A substance for lowering high cholesterol level in serum and a method for preparing the same |
| 08/06/1997 | EP0585397B1 Bombesin analogs |
| 08/06/1997 | EP0502845B1 Human high-affinity neurotransmitter uptake system |
| 08/06/1997 | CN1156451A Quinoline derivatives as tachykinin NK3 receptor antagonists |
| 08/05/1997 | US5654468 Antilipid, anticholesterol agents |
| 08/05/1997 | US5654445 Intermediates for renin inhibitors, hypotensive agents |
| 08/05/1997 | US5654326 1H-indole-3-glyoxylamide SPLA2 inhibitors |
| 08/05/1997 | US5654313 Administering a prolactin-inhibiting compound and subsequently a prolactin-stimulating compound |
| 08/05/1997 | US5654303 Alkyl amine derivatives of substituted quinoxaline 2,3-diones as glutamate receptor antagonists |
| 08/05/1997 | US5654001 Dietary lipid digestion-absorption inhibitory agents and ingesta |
| 08/05/1997 | US5653975 Implanting encapsulated cells capable of producing human growth factor or trophic factor for diffusion into the central nervous system; treatment of diabetes; anemia; hypoparathyroidism; parkinson's and alzheimer's disease |
| 08/05/1997 | CA2049119C Lipoprotein removal by soluble enzymes |
| 07/31/1997 | WO1997027191A1 Novel polymorphic forms of troglitazone having enhanced anti-diabetic activity and a process for their preparation |
| 07/31/1997 | WO1997027185A1 Piperidone tachykinin antagonists |
| 07/31/1997 | WO1997026916A1 Obesity protein analog compounds and formulations thereof |
| 07/31/1997 | WO1997026903A1 Microencapsulated genetically engineered microorganisms for clinical application |
| 07/31/1997 | WO1997026853A2 Dna encoding galanin galr2 receptors and uses thereof |
| 07/31/1997 | WO1997026804A1 Enteral formula or nutritional supplement containing arachidonic and docosahexaenoic acids |
| 07/31/1997 | WO1997026790A1 APOPTOSIS INDUCED BY SHIGELLA IpaB |
| 07/31/1997 | WO1997022360A3 Control of protein synthesis, and screening method for agents |
| 07/31/1997 | CA2247368A1 Enteral formula or nutritional supplement containing arachidonic and docosahexaenoic acids |
| 07/31/1997 | CA2216227A1 Dna encoding galanin galr2 receptors and uses thereof |
| 07/30/1997 | EP0786473A2 Basic protein composition, basic peptide composition and application thereof |
| 07/30/1997 | EP0786256A2 Obesity protein formulations |
| 07/30/1997 | EP0785948A1 Analogs of keratinocyte growth factor |
| 07/30/1997 | EP0785944A1 Acyl amino acetamide derivatives with agonist activity for cck-a receptors |
| 07/30/1997 | EP0785933A1 Indole derivatives as 5ht1-like agonists |
| 07/30/1997 | EP0785803A1 Use of a non-mammalian dna virus to express an exogenous gene in a mammalian cell |
| 07/30/1997 | EP0785794A1 Enteric coated compositions of 1,5-benzodiazepine derivatives having cck antagonistic or agonistic activity |
| 07/30/1997 | EP0785787A1 Use of 1,5-benzodiazepine derivatives for the control of gastric emptying in patients with non-insulin dependent diabetes mellitus |
| 07/30/1997 | EP0785785A1 Methods of inhibiting conditions associated with neuropeptide y |
| 07/30/1997 | EP0785784A1 4-heterocyclic piperidines promote release of growth hormone |
| 07/30/1997 | EP0785781A2 Use of indole derivatives for the treatment of dermatological disorders peripheral neuropathied, arthritis, headache, orofacial pain, allergic or chronic obstructive airways disease, glaucoma and ocular inflammation |
| 07/30/1997 | EP0785769A1 Therapeutic vitamin-calcium combination in unitary galenic tablet form, method for preparing same and use thereof |
| 07/30/1997 | EP0735859B1 A pharmaceutical composition for the intranasal administration of hydroxocobalamin |
| 07/30/1997 | EP0687263B1 Process for preparing (trans)-6- [2-(substituted-pyrrol-1-yl)alkyl]pyran-2-one inhibitors of cholesterol synthesis |
| 07/30/1997 | EP0547099B1 Product containing growth factor and glutamine and use of growth factor for the treatment of intestinal mucosa |
| 07/30/1997 | CN1155886A Salts of an anti-migraine indole derivative |
| 07/30/1997 | CN1155838A Indolinone compounds for the treatment of disease |
| 07/30/1997 | CN1155538A Substituted imidogen sulfamide, its preparation, use and medicines containing the same |
| 07/29/1997 | US5652339 Method of producing reconstituted lipoproteins |